Per NCCN if normal DRE and high risk w PSA 3 or average risk w PSA 1 3 ng mL retest q1 2y 8

By rray, 1 August, 2024
Detail (Long)
Per NCCN, if normal DRE and high risk w/ PSA ≤3, or average risk w/ PSA 1-3 ng/mL, retest q1-2y.<sup>8</sup>